patients with nontyphoid salmonellosis were admitted to our hospital; of these patients, 121 had primary bacteremia, and 28 had endovascular infection. Of the 121 patients with primary bacteremia, 64 were aged 150 years, and 26 had endovascular infection. Overall, 90 patients (29.9%) had immunodeficiency. Predictors of primary bacteremia were age; presence of systemic lupus erythematosus; group B, group C, or group D Salmonella infection; and immunodeficiency. The positive predictor of endovascular infection in adult patients with primary bacteremia was group C Salmonella infection, and negative predictors were immunodeficiency and solid-organ cancer. The overall in-hospital mortality rate was 12%; for primary bacteremia, it was 24.8%; for endovascular infection, it was 14.3%. Predictors of in-hospital death were age, extraintestinal infection, and solid-organ malignancy.
fection, and therapeutic immunodeficiency [4] [5] [6] . The occurrence of primary bacteremia (i.e., bacteremia without associated recent gastrointestinal symptoms) is ominous and should prompt clinicians to consider whether an immunodeficiency is present. In adults, nontyphoid Salmonella bacteremia is even more serious. Salmonella infection may manifest in 5 different clinical forms: asymptomatic chronic carrier state, gastroenteritis, enteric fever, bacteremia, and extraintestinal localized complications [7] . A feared complication is the development of endovascular infection (e.g., infective endocarditis and infected aortic aneurysm), and the prognosis for patients with this condition is poor [8] [9] [10] [11] [12] . Endovascular infections are rare complications of salmonellosis. Frequently, the diagnosis is not established until the patient has an advanced stage of the disease. Anatomical disruptions, including atherosclerotic en-dovascular lesions and prosthetic devices, may all serve as foci for persistent Salmonella infection. Because of the insidious onset and poor prognosis of this condition, it is important to treat patients with nontyphoid salmonellosis during the early stage, before the development of endovascular infection [12] . Nontyphoid salmonellosis in compromised hosts can result in bacteremia and endovascular infection, leading to a high mortality rate. However, limited data from risk factor analysis for endovascular infection in patients with nontyphoid salmonellosis have been reported [13] . To ascertain which patients with known Salmonella infection are most likely to have primary bacteremia and endovascular infection, we retrospectively analyzed the medical records for patients with nontyphoid salmonellosis from a 6-year period.
PATIENTS AND METHODS

Patients.
A retrospective analysis of the clinical and bacteriologic data for all patients with nontyphoid salmonellosis during the period of September 1995 through September 2001 was performed. Patients were included in this study if they had у1 culture positive for nontyphoid salmonellae. Patients infected with Salmonella enterica serotype Typhi and S. enterica serotype Paratyphi were excluded from the study. Because polymicrobial infection was common, HIV-infected patients were also excluded. When recurrence of Salmonella infection with the same organism occurred in the same patient, only the first episode was included in analysis.
Data collection. The medical records were reviewed, and data on demographic characteristics (age and sex), underlying disease (systemic lupus erythematosus, hematologic malignancy, and solid-organ malignancy), clinical presentation (fever and diarrhea), bacteriology (Salmonella serogroups A-E and G), and in-hospital outcome (survival or death) were recorded. "Primary bacteremia" was defined as bacteremia without associated recent gastrointestinal symptoms. "Secondary bacteremia" was defined as bacteremia with recent gastrointestinal symptoms (diarrhea) or a positive stool culture result. "Immunodeficiency" was defined as suppression of the immune system that occurred with receipt of steroid therapy, chemotherapy for malignancy, and immunosuppressive therapy for organ transplantation.
Bacteriology. Salmonella isolates were initially identified using biochemical tests. Serogrouping was performed by agglutination testing with use of antisera specific to O antigen. Serotypes were not routinely determined.
Patients were classified into 4 groups: (1) those with intestinal salmonellosis, who had diarrhea and a stool culture positive for salmonellae; (2) those with extraintestinal salmonellosis, who had an extraintestinal focus of infection and salmonellae isolated from blood culture and culture of a sample other than a stool specimen; (3) those with primary bacteremia, who had no focus of infection and who had a blood culture positive for salmonellae; and (4) those with endovascular infection, who had infective endocarditis, infected aortic aneurysm, or infection in intravascular implants that was documented by an imaging study or a tissue culture.
Statistical analysis. Analysis was performed using the x 2 test, Fisher's exact test, and the Mann-Whitney U test. Stepwise logistic regression was used to identify risk factors for primary bacteremia, endovascular infection, and in-hospital death.
RESULTS
Patients.
From September 1995 through September 2001, 301 patients with nontyphoid salmonellosis were admitted to our hospital. Of these patients, 175 had intestinal Salmonella infection, 39 of whom had secondary bacteremia; 5 had focal extraintestinal infection without bacteremia; and 121 had primary bacteremia, 28 of whom had endovascular infection. Among the 28 endovascular infections, there were 2 cases of infective endocarditis, 25 infected aortic aneurysms, and 1 infected vascular graft of arteriovenous fistula. In total, there were 165 patients who had extraintestinal Salmonella infection, including 39 patients who had secondary bacteremia, 121 patients who had primary bacteremia, and 5 patients who had focal infection without bacteremia. There were 43 patients who had metastatic infection, including 28 patients with endovascular infection, 3 with infected pleural effusion, 3 with postoperative wound infection, 2 with urinary tract infection, 2 with osteomyelitis, 2 with bone marrow infection, 1 with arthritis, 1 with pneumonia, and 1 with softtissue infection.
Salmonella serogroups. Three cases (1.0%) of salmonellosis involved group A Salmonella organisms, 137 (45.5%) involved group B, 58 (19.3%) involved group C, 71 (23.6%) involved group D, 5 (1.7%) involved group E, and 1 (0.3%) involved group G. The serogroup was unidentified in 26 cases (8.6%). The distribution of serogroups did not change during the study period. Among 28 cases of endovascular infection, only 3 serotypes were identified: S. enterica serotype Typhimurium, in 2 cases, and S. enterica serotype Choleraesuis, in 1 case.
Risk factor analysis. Overall, 90 patients (29.9%) had an immunodeficiency. Table 1 shows clinical data and infectious Salmonella serogroups for patients who had primary bacteremia and for those who did not. Compared with patients who did not have primary bacteremia, patients who had primary bacteremia were older and were more likely to have underlying diseases or risk factors, such as immunodeficiency, systemic lupus erythematosus, and solid-organ malignancy. Table 1 also shows the clinical data and infectious Salmonella serogroups for bacteremic patients who had endovascular infection and for those who did not. Compared with bacteremic patients who did not have endovascular infection, bacteremic patients who had endovascular infection were older and were more likely to have underlying diseases or risk factors, including immunodeficiency, systemic lupus erythematosus, and solid-organ malignancy. Table 2 shows clinical data, infectious Salmonella serogroups, and outcomes for adults (age, у18 years) and children with nontyphoid salmonellosis. Adult patients had more group D and fewer group B infections than did children. Adult patients had more underlying diseases, including immunodeficiency, systemic lupus erythematosus, and solid-organ malignancy; more clinical presentations of primary bacteremia, extraintestinal infection, and endovascular infection; and a higher mortality rate. Table 3 shows the predictors of primary bacteremia, as determined by stepwise logistic regression. Predictors of primary bacteremia were older age; presence of systemic lupus erythematosus; infection with group B, group C, or group D Salmonella organisms; and immunodeficiency. Table 4 shows the predictors of endovascular infection in adult patients, as determined by stepwise logistic regression. The positive predictor of endovascular infection was infection with group C Salmonella organisms, and negative predictors were immunodeficiency and solid-organ malignancy.
In-hospital outcome. Overall, 36 patients (12.0%) died in the hospital. The in-hospital mortality rate was 2.2% (3 of 136 patients) for intestinal salmonellosis without secondary bacteremia, 7.7% (3 of 39 patients) for intestinal salmonellosis with secondary bacteremia, 20% (33 of 165 patients) for extraintestinal salmonellosis, 24.8% (30 of 121 patients) for primary bacteremia, and 14.3% (4 of 28 patients) for endovascular infection. Table 5 shows the predictors of in-hospital death for patients with nontyphoid salmonellosis. Predictors of inhospital death were older age, extraintestinal infection, and solid-organ malignancy.
DISCUSSION
Salmonellae are uncommon blood culture isolates in the developed world. The frequency of secondary bacteremia among patients with intestinal nontyphoid salmonellosis is estimated to be 2%-5% [14, 15] . The high incidence of secondary bacteremia in our study (39 of 175 patients) may be the result of a selection bias of hospitalized patients. The majority of patients with intestinal Salmonella infection who did not have bacteremia were treated at the outpatient clinic. The highest incidences of bacteremia have been reported among patients with infections due to uncommon Salmonella serotypes, but this has [16] . Salmonella bacteremia is often transient and benign, but it may cause serious disease. Patients with immunodeficiency are more predisposed to invasive salmonellosis. In some patients, Salmonella bacteremia is not associated with gastrointestinal symptoms, and this may be a marker of underlying immunodeficiency [1, [4] [5] [6] . We found similar results. Of the 301 cases in our study, 45.5% involved group B, and 23.6% involved group D. Old age, systemic lupus erythematosus, and immunodeficiency were positive predictors of primary bacteremia. Endovascular infection is an important complication that may be difficult to treat. Previously, this complication was almost always fatal, but a review of 140 cases reported from 1948 through 1999 found a 60% mortality rate for all patients; the mortality rate was 96% for patients treated only medically and 38% for patients treated with combined surgical and medical therapy [8] . The in-hospital mortality rate for endovascular infection (14.3%) was low in our series. Techniques used for surgical management and postoperative management were based on the treatment of infected aortic aneurysm [17] . Several factors were responsible for improved survival in our series. A high index of suspicion, early diagnosis, avoidance of unnecessary immediate surgical resection, and administration of more-effective antibiotic therapy appear to be of the utmost importance [17] .
The incidence of endovascular infection and its risk factors were not properly reported in prior studies. Previous studies conducted in Western countries found that ∼10% of bacteremic adults aged 150 years developed endovascular infection [5, 13, 18] . A Taiwanese study published in 1996 found that 35% of bacteremic adults aged 165 years had aortitis [19] . Of our 121 patients with primary bacteremia, 64 patients (52.9%) were aged 150 years, and 26 (40.6%) of those patients had endovascular infection. This high incidence of endovascular infection prompted us to perform extensive imaging studies for our patients with primary Salmonella bacteremia.
Traditionally, patients with immunodeficiency were thought to be susceptible to Salmonella endovascular infection. In 1978, Cohen et al. [13] reported that persons aged 150 years who have Salmonella bacteremia and clinical evidence of infection before hospitalization appear to constitute a high-risk group for endovascular infection. Whether immunodeficiency was a risk factor was not mentioned. Despite a high rate of Salmonella bacteremia among patients with systemic lupus erythematosus and HIV infection, endovascular infection has been rarely described in these immunocompromised patients [20] [21] [22] . In our (table 4 ). In addition, old age is an independent and a most important risk factor for both primary bacteremia and endovascular infection. Age-related degenerative diseases, such as atherosclerosis, may be more important than immunodeficiency, systemic lupus erythematosus, and malignancy as causes of endovascular infection. A number of host factors can predispose to extraintestinal Salmonella infection. However, even in the susceptible host, certain serotypes of salmonellae are more likely to cause systemic infection. There are 12000 serotypes of nontyphoid salmonellae. Certain serotypes are particularly associated with systemic infections [15] . These serotypes are also more likely to cause invasive infections in people with no identifiable immunodeficiency. Almost all Salmonella infections in humans (195%) are caused by salmonellae that are in serogroups A, B, C, D, and E. In the late 1990s, S. Typhimurium and S. Enteritidis were the most frequently isolated serotypes, accounting for 50% of isolates recovered from patients in the United States [1] . Certain serotypes cause primary bacteremia, such as S. Choleraesuis (serogroup C) and S. enterica serotype Dublin (serogroup D1); for both of these, the ratio of blood to fecal isolates is extremely high. Others-notably, S. Typhimurium and S. Enteritidis-are usually enteric pathogens and occasionally can cause secondary bacteremia [15] .
One of the important findings of our study is the major difference in nontyphoid Salmonella serogroup distribution among patients with intestinal salmonellosis, those with primary bacteremia, and those with endovascular infection. For patients with intestinal salmonellosis and patients with primary bacteremia, there were 3 predominant Salmonella serogroups (group B [45.5%], group C [19.3%] , and group D [23.6%]), whereas, for patients with endovascular infection, group C salmonellae predominated (46.4%). Previous reviews of the literature on Salmonella infection-associated aortitis found that group C salmonellae accounted for !25% of infections [5, 9] . The emergence of group C Salmonella organisms as a major pathogen in our study is of interest. Group C salmonellae are not universally recognized as causes of nontyphoid Salmonella bacteremia. In a 1999 Taiwanese study of 436 clinical isolates by Chiu et al. [23] , S. Typhimurium was still the most common serotype isolated in Taiwan, followed (in order of frequency) by S. enterica serotype Schwarzengrund and S. Choleraesuis. However, S. Choleraesuis is the most common pathogen (74%) among Salmonella serogroup C, and it is the most virulent serotype to humans in Taiwan [23, 24] . Pigs in Taiwan were considered to be a potential source of the invasive Salmonella infection [25] . The high incidence of Salmonella group C in our study may have contributed to the high incidence of endovascular infection and improved in-hospital outcome among patients with nontyphoid salmonellosis.
The major limitation of our study is lack of serotype determination, and the result for our patients was preliminary. There are many serotypes in a serogroup, and only serogroup (not serotype) was reported to have specific invasiveness [24] . In addition, the hospital-based data from our study are not comparable with the community-wide public health data from the study of Chiu et al. [24] . However, this is the first study and among the largest series to analyze both host and bacterial factors in cases of Salmonella endovascular infection. Further serotype determination and study of serotype invasiveness may provide more information about the pathogenesis of endovascular infection in patients with nontyphoid salmonellosis.
In conclusion, nontyphoid Salmonella bacteremia was asso-ciated with old age, systemic lupus erythematosus, and immunodeficiency. The incidence of endovascular infection among adult patients with Salmonella bacteremia was high in Taiwan. Serogroup C salmonellae, but not systemic lupus erythematosus or immunodeficiency, predisposed patients to endovascular infection.
